๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Paris
Clinical trial register · France

Clinical Trials in Paris, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 9693 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:56 UTC
9693
Studies in scope
all four open statuses
6031
Recruiting now
open to new participants
1035
Lead sponsors
across recruiting studies
Top sites
Paris 7 Brest 5 Crรฉteil 5 Pessac 5 Toulouse 5
Narrow the registerReset
Recruitment status
Phase
Site location
Paris7 Brest5 Crรฉteil5 Pessac5 Toulouse5
All 30 locations
Target enrolment
to

Trials with a site in Paris

7 of 9693 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
NCT07444567Asthma, Eosinophilic Granulomatosis With Polyangiitis (EGPA), Hypereosinophilic Syndrome (HES)
AstraZeneca
Phase 3
230
Bron, Marseille, Montpellier, Nantes, Paris, Pessac, Suresnes
2026-07-24
Recruiting
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
NCT07219173Asthma
Eli Lilly and Company
Phase 2
531
Aix-en-Provence, Brest, Cholet, Le Chesnay, Le Kremlin-Bicรชtre, Montfermeil, Paris, Pessac
2025-10-22
Active, closed
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
NCT06676319Asthma
Sanofi
Phase 2
556
Amiens, Lyon, Montpellier, Paris, Pessac, Strasbourg, Toulouse
2024-11-07
By invitation
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
NCT06191315Wheezing, Asthma
Sanofi
Phase 3
90
Crรฉteil, Lille, Nice, Paris
2024-01-03
Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
NCT06023589Asthma
AstraZeneca
Phase 3
231
Brest, Bron, Crรฉteil, Marseille, Paris, Rouen, Vandล“uvre-lรจs-Nancy
2023-08-24
Active, closed
Symptoms Control and adhErenCe Assessment During Treatment With MepolizUmab New pREfilled Devices
NCT05626777Asthma
Hospices Civils de Lyon
Phase 4
20
Besanรงon, Dijon, Lille, Lyon, Montpellier, Paris, Reims, Toulouse
2023-03-09
Recruiting
Short Treatment with Omalizumab for Severe Asthma
NCT04763447Asthma
Assistance Publique - Hรดpitaux de Paris
Phase 4
234
Paris
2021-05-20
Rows per page Showing 1–7 of 7
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-france/city/paris

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,693 studies in total at the last sync on 26 Sep 2026, 19:56 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 7 of those studies with a site in Paris that also match the filters currently applied.

How many clinical trials are recruiting in Paris?

4 of the 7 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:56 UTC sync. A further 0 have not yet opened recruitment, 2 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Paris), 7 studies
PhaseStudiesRecruitingShare
Phase 33242.9%
Phase 22128.6%
Phase 42128.6%

Most active sponsors

Lead sponsors with the most studies (Paris)
Lead sponsorStudiesRecruiting
AstraZeneca22
Sanofi20
Assistance Publique - Hรดpitaux de Paris11
Eli Lilly and Company11
Hospices Civils de Lyon10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.